Avricore Health Corporate Update and Private Placement Extension
Avricore Health Inc. (TSXV:AVCR, OTC:AVCRF) ("Avricore Health" or the "Company") is pleased to provide an update on the significant progress the...
OrthoPediatrics Receives FDA Clearance for Pediatric-Specific Foot System
OrthoPediatrics (NASDAQ:KIDS) has announced it has received 510(k) clearance from the US Food and Drug Administration (FDA) For its PediFoot...
T2 Biosystems Expands Rapid Diagnostic Technologies to Australia, Fiji and New Zealand
T2 Biosystems (NASDAQ:TTOO) has announced it has expanded its diagnostic technologies, including T2Bacteria and T2Candida Panels, to Australia, Fiji and...
Profound Medical Receives FDA Clearance for TULSA-PRO®
Profound Medical (TSX:PRN, OTCQX:PRFMF) has announced it has received 510(k) clearance from the US Food and Drug Administration to market...
Avricore Health Closes $340K First Tranche of Placement
Avricore Health Inc. (TSXV:AVCR, OTC:AVCRF) ("Avricore Health" or the "Company") announces that it has closed the first tranche of its previously...
Anika Therapeutics Completes First Human Surgical Procedure with Injectable HA-Based Bone Repair Therapy
Anika Therapeutics (NASDAQ:ANIK) has announced it has completed the first human surgical procedure with its injectable HA-based bone repair therapy...
Misonix Announces CE Mark Approval for Nexus
Misonix (NASDAQ:MSON) has announced it has received CE Mark approval for its Nexus medical device. As quoted in the press...